000 01936cam  2200373zi 4500
0019.905143
003CaOODSP
00520230116143903
006m     o  d f      
007cr cn|||||||||
008211119t20222022onca    o    f000 0 eng d
020 |a9780660410210
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP2-4/2019E-3-PDF
24500|aCanadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2019 : |bdesign and methods.
24617|aCIPARS 2019 : |bdesign and methods
264 1|aOttawa, ON : |bGovernment of Canada = Gouvernement du Canada, |c2022.
264 4|c©2022
300 |a1 online resource (66 pages) : |billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"Publication date: December 2022."
500 |aIssued by: Public Health Agency of Canada.
500 |aIssued also in French under title: Programme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) 2019 : design et méthodes.
520 |a"In 2019, sales data collected from Veterinary Antimicrobial Sales Report (VASR), a collaborative initiative between Public Health Agency of Canada and Health Canada, were included in this report"--Page 2.
61020|aCanadian Integrated Program for Antimicrobial Resistance Surveillance.
650 0|aDrug resistance in microorganisms|zCanada.
650 0|aAnti-infective agents|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tProgramme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) 2019 : |w(CaOODSP)9.905144
795 |tCanadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2018 : |w(CaOODSP)9.894244
85640|qPDF|s4.86 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP2-4-2019-3-eng.pdf